F-star Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2015 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
F-star Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2015 to Q3 2022.
  • F-star Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$13.7M, a 42.8% decline year-over-year.
  • F-star Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$36.8M, a 16.5% increase year-over-year.
  • F-star Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$30.7M, a 37.2% decline from 2020.
  • F-star Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$22.4M, a 0.5% increase from 2019.
  • F-star Therapeutics, Inc. annual Operating Income (Loss) for 2019 was -$22.5M, a 21% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$36.8M -$13.7M -$4.11M -42.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$32.6M -$16.2M -$1.39M -9.39% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$31.3M -$11.2M -$544K -5.11% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 -$30.7M $4.32M +$13.3M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 -$44M -$9.6M -$6.21M -183% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$37.8M -$14.8M -$10M -209% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$27.8M -$10.6M -$5.41M -103% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$22.4M -$8.98M -$12.1M -388% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$10.3M -$3.39M +$4.09M +54.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$14.4M -$4.79M +$4.98M +51% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$19.4M -$5.23M +$3.14M +37.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$22.5M $3.12M +$9.72M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$32.2M -$7.48M +$240K +3.11% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 -$32.5M -$9.77M -$1.81M -22.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$30.6M -$8.38M -$2.18M -35.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$28.5M -$6.6M -$311K -4.94% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-14
Q3 2018 -$28.2M -$7.72M -$2.53M -48.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$25.6M -$7.95M -$2.69M -51.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 -$22.9M -$6.2M -$1.69M -37.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 -$21.3M -$6.29M -$1.92M -43.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-11
Q3 2017 -$19.3M -$5.19M -$1.01M -24.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-25
Q2 2017 -$18.3M -$5.26M -$938K -21.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$17.4M -$4.51M +$2.02M +30.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 -$19.4M -$4.37M -$409K -10.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-20
Q3 2016 -$19M -$4.18M -$768K -22.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$18.2M -$4.32M -$2.05M -90.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-31
Q1 2016 -$16.2M -$6.54M -$4.58M -234% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 -$11.6M -$3.96M Oct 1, 2015 Dec 31, 2015 10-K 2017-02-14
Q3 2015 -$3.41M Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 -$2.27M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 -$1.96M Jan 1, 2015 Mar 31, 2015 10-Q 2016-06-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.